Labshake search
Citations for R&D Systems :
501 - 550 of 3996 citations for 2R 5S 5 4 amino 5 fluoro 2 oxopyrimidin 1 2H yl 1 3 oxathiolan 2 yl methyl butyrate WXC04778 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... and 40 ng/ml FGF-2 (R&D Systems) on poly-lysine (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... 2% Noggin/R-Spondin–conditioned media (R&D Systems), 100 ng/mL recombinant human Wnt3A (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... mIL-2 (10 ng/ml; R&D Systems Inc) was added to the culture medium from day 1 to expand iTregs ...
-
bioRxiv - Developmental Biology 2023Quote: ... and IGF-2 (#292-G2-250, R&D systems). Additionally ...
-
bioRxiv - Cell Biology 2023Quote: ... or TGF-ϕ31 (2 ng/ml; R&D System). For viral transduction ...
-
bioRxiv - Microbiology 2024Quote: ... SARS-CoV-2 spike S2 (MAB10557, R&D systems), VSV-M[23H12] (Ab01404-2.0 ...
-
bioRxiv - Immunology 2024Quote: ... resuspended in BME type 2 (R&D Systems, 353300502), and cultured as previously described111 ...
-
bioRxiv - Molecular Biology 2024Quote: ... Slit homolog 2 (SLIT2)(R&D Systems, # 8616-SL), CXCL6 (R&D Systems ...
-
bioRxiv - Biophysics 2024Quote: ... and N-2 Max (100x, R&D Systems, AR009). 35mm dishes were pre-coated with 10x diluted Matrigel (Corning ...
-
bioRxiv - Cell Biology 2024Quote: ... and WIN 55,212-2 (R&D Systems, cat# 1038) were resuspended in DMSO and added to the cells 3 minutes prior to starting recordings ...
-
bioRxiv - Cancer Biology 2023Quote: ... 0.3% Triton X-100) for 1 hour at room temperature and incubated with primary antibody against VE-cadherin (AF938, R&D Systems, 1:100) overnight at 4°C ...
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Immunology 2024Quote: ... and 5 µg/ml anti-GM-CSF (MP122E9, R&D Systems) or 1 µg/ml anti-PECAM-1 (MEC13.3 ...
-
bioRxiv - Developmental Biology 2024Quote: ... media was replaced with 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Genetics 2024Quote: ... and 5 ng/ml recombinant human IL-15 (R&D Systems). After two days of activation ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 1X B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/mL GDF-5 (R&D Systems, Minneapolis, MN, USA), and 0.05 mM L-ascorbic acid 2-phosphate ...
-
bioRxiv - Immunology 2020Quote: ... cells were pelleted and resuspended in 100 µL FACS buffer (2% FBS in DPBS) containing 0.2 µg goat-α-human Ace-2 (R&D Systems #AF933). After 30 min on ice ...
-
bioRxiv - Immunology 2020Quote: ... Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems; R15-100). R15-100 was added every 2 to 3 days thereafter ...
-
bioRxiv - Genomics 2021Quote: ... Polyclonal Goat Anti- Human/Mouse Oct-3/4 Antibody (R&D System, AF1759,1:20).
-
bioRxiv - Molecular Biology 2023Quote: Polystyrene microtiter plates were coated with 1 µg/ml recombinant SARS-CoV-2 spike protein produced in HEK293T cells (10549-CV-100, R&D Systems and Biotech, NE, MN, USA) while some plates were coated with 50 ng/ml SARS-CoV-2 S protein RBD or Biotinylated hACE2 (0.2 µg/ml ...
-
bioRxiv - Biochemistry 2022Quote: ... or 1:1000 anti-Human/Mouse/Rat PRL-3 Antibody (R&D Systems, MAB3219, Lot. WXH0419091). Following three washes with 0.1% TBST ...
-
bioRxiv - Cancer Biology 2024Quote: Xenograft studies were performed by subcutaneous bilateral implantation of 5E6 tumor cells/injection suspended 100 µl of 1: 1 RPMI / BME type 3 (R&D Systems #36-320-1002P). 4 to 6-week-old NOD-scid IL2Rgnull (NSG ...
-
bioRxiv - Cancer Biology 2024Quote: ... Approximately 2 x 106 cells were injected in 100 µL of a 1:1 (v/v) mixture of Cultrex basement membrane extract (BME) type 3 (Biotechne R&D Systems, Minneapolis, MN, USA) and sterile 1X phosphate buffered saline (PBS) ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by 4 hour incubation with mouse anti-O4 IgM (1:1000; R&D Systems) and rat anti-MBP (1:500 ...
-
bioRxiv - Cancer Biology 2022Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5μg/mL and 20IU/mL ...
-
bioRxiv - Microbiology 2022Quote: ... The resulting supernatant was used to measure levels of inflammation marker Lipocalin-2 using the Duoset murine Lcn-2 ELISA kit (R&D Systems, Minneapolis, MN).
-
bioRxiv - Evolutionary Biology 2023Quote: Lipocalin-2 concentration in the supernatants was measured using the commercial kit Mouse Lipocalin-2/NGAL DuoSet ELISA (R&D Systems, Minneapolis, MN, USA) for mouse Lipocalin-2 (DY1857) ...
-
bioRxiv - Immunology 2024Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5µg/mL and 20IU/mL ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by incubation with the appropriate primary antibodies in blocking solution at 4°C overnight (1:1000 rabbit anti-IBA1 (FujiFilm Wako Chemicals, Cat # 019-19741) & 1:500 sheep anti-TREM2 (R&D Systems, Cat # AF1729)) ...
-
bioRxiv - Immunology 2021Quote: ... anti-IL-4 (1 μg/ml) R&D Systems Cat# MAB204) and anti-IFN-γ (1 μg/ml R&D Systems Cat#MAB-285). Differentiation of Th17 cells was confirmed by measuring IL-17 expression by quantitative real-time PCR ...
-
bioRxiv - Molecular Biology 2022Quote: ... samples were incubated at 4°C overnight with the respective primary antibodies (LDLR, R&D Systems, 1:200 and CAP1, Santa Cruz, 1:1,000). Cells were then washed with PBS and incubated with the appropriate fluorescent secondary antibody (all from Thermo Fisher ...
-
bioRxiv - Systems Biology 2024Quote: ... incubated overnight at 4°C in PBST with the following primary antibodies: mouse SHH supernatant (DSHB, 1:70) and sheep ARX (R&D systems, 1:100), washed in PBST ...
-
bioRxiv - Immunology 2022Quote: ... 2 ng/mL recombinant human TGF-β1 (R&D Systems), and 333 ng/mL anti-IgD dextran conjugates (Fina Biosolutions) ...
-
bioRxiv - Immunology 2021Quote: ... 100 IU/ml recombinant human IL-2 (R&D Systems), and 50 μM beta-mercaptoethanol (Fisher) ...
-
bioRxiv - Bioengineering 2021Quote: ... Human/Mouse/Rat/Hamster ACE-2 (R&D systems, AF933), Human TRA-1-85/CD147 (R&D systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 50 IU/mL of IL-2 (R&D Systems)] for 7 days prior to use in cell killing assays ...